Le Lézard
Classified in: Health
Subjects: POL, VET

Wounded Warrior Project, Veterans Service Organizations, and Congressional Leaders Announce Passage of "Death Gratuity" Payment Reform Bill


WASHINGTON, Sept. 18, 2018 /PRNewswire/ -- Wounded Warrior Project® (WWP) applauds the addition of H.R. 1928 Families of The Fallen Service Members Act to the minibus carrying the defense appropriations package and is proud to have led the way in advocating for this important change to the law. This bill protects military families from being inadvertently and adversely impacted by government shutdowns that suspend immediate financial assistance to families whose loved one dies while on active duty.

Wounded Warrior Project® (WWP) applauds the addition of H.R. 1928 Families of The Fallen Service Members Act to the minibus carrying the defense appropriations package and is proud to have led the way in advocating for this important change to the law.

When a servicemember loses their life while serving on active duty, their family is provided a tax-free stipend of $100,000, known as a death gratuity payment. Grieving families rely on these funds to address immediate financial impacts that often occur after the death of a servicemember ? such as travel and lodging for family members to travel for the return of remains; funeral costs; and other expenses that are unique to military families. In the past when the government has shut down, these funds were frozen until the shutdown expired, and military nonprofit groups generously contributed to families to cover what the government should have immediately provided.    

Through a unified advocacy effort between Tragedy Assistance Program for Survivors (TAPS), the Military Order of the Purple Heart, and WWP, along with help from other veterans service organizations, Congress announced they would authorize death gratuity payments even during a government shutdown.

"While infrequent, government shutdowns, which are inherently political, had an unfortunate and egregious impact on those who sacrifice most for our country," said René Bardorf, WWP Vice President of Government Affairs and Community Relations. "Unfortunately, service personnel may be wounded, injured, or become ill in the line of duty, and sadly that sometimes results in the untimely death of our young heroes who serve us. That's why over the past year Wounded Warrior Project has worked alongside numerous veterans service organizations and senior government officials to advocate on behalf of our families of the fallen."

To read more about this bill, including statements from TAPS, Military Order of the Purple Heart, Sen. Chris Coons of Delaware and Rep. Gerald Connolly of Virginia's 11th District, visit: https://newsroom.woundedwarriorproject.org/highlights?item=31026.  

About Wounded Warrior Project
Since 2003, Wounded Warrior Project® (WWP) has been meeting the growing needs of warriors, their families, and caregivers ? helping them achieve their highest ambition. Learn more: http://newsroom.woundedwarriorproject.org/about-us.

SOURCE Wounded Warrior Project


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: